MAY 11, 2016 05:00 AM PDT

Drug calms immune system after brain injuries

Scientists are testing a new drug that could minimize the risk of life-threatening infections in patients with traumatic brain injuries.
 
"If our findings can be translated into humans this could be life-changing for patients with head injuries," says Claire Harris.

The infections, as well as brain inflammation, are the result of the body’s natural disease-fighting immune response, called “complement.”

“When tissue is injured in an accident, this part of our immune system sees the tissue as ‘foreign’ and responds in an inappropriate way to make the damage even worse,” says Claire Harris, a professor from Cardiff University’s Institute of Infection and Immunity, who led the research.

Harris and colleagues have engineered a new duel “homing” agent that, when given to mice, inactivated the complement system in the brain, reduced inflammation, and aided recovery.

“Widespread blocking of this part of the immune system after traumatic brain injury helps damaged brain tissue to survive and improves neurological recovery in mice. Unfortunately, this treatment approach could be harmful to humans because complement is essential for fighting infections—that’s why this homing agent is so significant.

“We have engineered a drug that combines two different activities in one molecule. One arm ‘targets’ the drug to the site of tissue damage, thus concentrating the therapy exactly where it is most needed, and the second arm (CD59) inhibits a specific part of the complement system that would drive further damage if left unchecked.

“This drug therefore delivers therapy to where it is needed, freeing up the complement system to fight infection in the rest of the body.”

The study, published in the Proceedings of the National Academy of Sciences, showed that when the homing agent was injected into mice immediately after traumatic brain injury, it specifically targeted the injured tissue, serving to inactivate the complement system and reduce inflammation and neuronal damage.

“Development of this new homing agent is exciting. We’ve shown that it can be administered in mice some time after the trauma and still be effective,” says Harris. “If our findings can be translated into humans this could be life-changing for patients with head injuries.”

Source: Cardiff University

This article was originally published on futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
SEP 15, 2019
Immunology
SEP 15, 2019
Vaccination Helps Prevent Diabetes
A drop in the number of young children diagnosed with type 1 diabetes could be associated with the introduction of routine rotavirus vaccination....
SEP 15, 2019
Immunology
SEP 15, 2019
Silent Inflammation, the Silent Problem
People who have chronic inflammation in middle-age may develop problems with thinking and memory...
SEP 15, 2019
Microbiology
SEP 15, 2019
How a Parasitic Amoeba Evades the Immune System
A parasitic amoeba that causes a gut disease can nibble on host cells and use their proteins. (Image courtesy UC Davis/Hannah Miller)...
SEP 15, 2019
Health & Medicine
SEP 15, 2019
Fourth-Generation Rapid Diagnostic Tests for Acute HIV-1 Infections
The ability to diagnose an acute HIV-1 infection before there are detectable antibodies to HIV 1/2 is critical to making an early diagnosis and getting the...
SEP 15, 2019
Cell & Molecular Biology
SEP 15, 2019
Visualizing the Maturation of T Cells in the Thymus
Scientists have visualized how the body tests out important defensive cells, and have captured the process on video....
SEP 15, 2019
Microbiology
SEP 15, 2019
Healthy Fat From a Beneficial Microbe May Help us Relieve Stress
We may one day be able to use a 'stress vaccine' to ward off the damage caused by traumatic events....
Loading Comments...